Skip to main content
. Author manuscript; available in PMC: 2020 Dec 8.
Published in final edited form as: J Med Chem. 2019 Nov 18;62(22):10182–10203. doi: 10.1021/acs.jmedchem.9b01065

Table 2.

The biological activity of TOP2A inhibitors using SW620 tumor organoid models of TCF-transcription, 3D cell viability, and EMT reporters of vimentin and E-cadherin.

Analog TCF Inhibition IC50 (μM) Cytotoxicity (CellTox Green) EC50 (μM) Vimentin downregulation EC50 (μM) E-cadherin upregulation EC50 (μM)
3 2.4 >30 4 9
7 2.4 >30 1.2 1.6
35 2.0 >30 9.5 5.5
39 4.7 >30 4.7 3.1
42 0.7 16 1.9 1.2
53 1.0 > 30 3.5 5.4
56 1.7 >30 1.7 3.4
57 5.0 >30 1.2 1.1
60 1.1 22 1.0 3.3
61 2.5 17.4 2.4 3.0